In this episode of Chromatography Life from Waters Corporation, Matthew Lauber, Senior Director and BioSeparations Leader at Waters Corporation, who shares his personal and professional journey while diving into the evolving landscape of synthetic peptide drugs. Tune in to hear more about the analytical challenges associated with GLP-1 therapies, and the chromatographic techniques that ensure their safety and efficacy.